Telangana is embarking on an ambitious journey to position itself as a global leader in the life sciences sector, with a bold target of attracting ₹1 lakh crore (approximately $12 billion) in investments by 2030. This initiative was announced by Duddilla Sridhar Babu, the Minister for IT and Industries, during his address at the AusBiotech International Conference 2025 held in Melbourne. The minister’s vision is not just about numbers; it’s about transforming the state into a vibrant hub for innovation, research, and development in life sciences.
The backdrop of this announcement is significant. Over the past 20 months, Telangana has already made remarkable strides, securing ₹3.2 lakh crore in new investments across various sectors, with ₹63,000 crore specifically from life sciences. This growth trajectory is indicative of the state’s potential and its strategic importance in the global life sciences landscape. The minister highlighted that exports from the life sciences sector reached ₹26,000 crore between April and December 2024, showcasing the robust demand for products and services emanating from Telangana.
One of the key components of this initiative is the “Roadmap 2030,” a comprehensive strategy designed to establish Telangana as a global hub for life sciences innovation. This roadmap is not merely a plan; it is a commitment to fostering an ecosystem that encourages research, collaboration, and investment. The state government is preparing a detailed Life Sciences Policy aimed at accelerating innovation, enhancing infrastructure, and forging global partnerships. This policy will serve as a guiding framework for stakeholders in the industry, ensuring that Telangana remains competitive and attractive to investors.
A notable aspect of this initiative is the projected creation of five lakh new jobs in the life sciences sector. This job creation is crucial not only for the economy of Telangana but also for addressing the growing demand for skilled professionals in biotechnology, pharmaceuticals, and healthcare. To meet this demand, the state is investing heavily in developing a “bio-digital workforce” equipped with skills in biotechnology, artificial intelligence, and healthcare technologies.
Education and training are pivotal to this vision. The establishment of the Life Sciences University and the Young India Skills University are state initiatives aimed at nurturing the next generation of talent. These institutions will focus on providing cutting-edge education and training programs that align with industry needs, ensuring that graduates are well-prepared to contribute to the evolving landscape of life sciences. Furthermore, Telangana is collaborating with the World Economic Forum’s Centre for the Fourth Industrial Revolution to align its educational programs with global standards, thereby enhancing the employability of its workforce.
The growth of life sciences office space in Hyderabad is another indicator of the sector’s momentum. From a mere 0.6 million square feet in 2022, the available office space has expanded to 2.4 million square feet in 2024. This exponential growth reflects the increasing interest from companies looking to establish a presence in Telangana. The state’s strong infrastructure, including Genome Valley, a dedicated medical devices park, B-Hub, Bharat Future City, and plug-and-play industrial parks, provides a conducive environment for businesses to thrive. These facilities are designed to support research and development activities, making it easier for companies to innovate and bring new products to market.
Minister Babu emphasized that Telangana’s strength lies in its innovation ecosystem. He articulated a vision that goes beyond the traditional “Make in India” slogan, advocating for “Invent in Telangana.” This shift in focus underscores the state’s commitment to fostering creativity and innovation, encouraging local entrepreneurs and researchers to develop groundbreaking solutions in life sciences.
The minister also extended an invitation to Australian companies and global players to invest in high-growth areas such as cell and gene therapy, biologics, mRNA vaccines, contract research and manufacturing, diagnostics, medtech, and digital health. These sectors are poised for significant growth, driven by advancements in technology and increasing demand for innovative healthcare solutions. By targeting these areas, Telangana aims to attract investments that will not only bolster its economy but also enhance its reputation as a leader in life sciences.
In addition to the aforementioned sectors, there are exciting opportunities in AI-driven drug discovery, genomics, green biomanufacturing, and agri-biotech. The integration of artificial intelligence in drug discovery processes is revolutionizing the way new therapies are developed, significantly reducing the time and cost associated with bringing new drugs to market. Similarly, advancements in genomics are paving the way for personalized medicine, allowing for treatments tailored to individual patients based on their genetic makeup.
Green biomanufacturing represents another frontier for Telangana, aligning with global sustainability goals. By leveraging biotechnology to produce sustainable products, the state can position itself as a leader in environmentally friendly manufacturing practices. Agri-biotech, on the other hand, holds the potential to transform agriculture through innovations that enhance crop yields, improve resistance to pests and diseases, and reduce the environmental impact of farming practices.
To support this ambitious growth trajectory, the Telangana government is committed to providing full support to all investors. This includes streamlining regulatory processes, offering incentives, and facilitating access to resources necessary for establishing and expanding operations in the state. The government’s proactive approach aims to create a favorable business environment that encourages both domestic and international investments.
The establishment of a “Victoria–Telangana Innovation Corridor” is another strategic initiative aimed at fostering collaboration between Telangana and Victoria, Australia. This corridor will facilitate knowledge exchange, joint research projects, and investment opportunities, further strengthening the ties between the two regions. By leveraging the strengths of both locations, the corridor aims to create a synergistic relationship that benefits stakeholders in the life sciences sector.
As Telangana embarks on this transformative journey, it is essential to recognize the broader implications of its ambitions. The state’s focus on life sciences is not just about economic growth; it is about improving healthcare outcomes for its citizens and contributing to global health advancements. By fostering innovation and attracting investments, Telangana can play a pivotal role in addressing some of the most pressing health challenges faced by society today.
In conclusion, Telangana’s ambitious target of attracting ₹1 lakh crore in life sciences investments by 2030 is a testament to its commitment to becoming a global leader in this critical sector. With a comprehensive roadmap, a focus on education and workforce development, and a strong emphasis on innovation, the state is well-positioned to achieve its goals. As it invites global players to join this journey, Telangana is not only shaping its own future but also contributing to the advancement of life sciences on a global scale. The coming years will be crucial in determining how effectively the state can leverage its strengths and capitalize on emerging opportunities in the ever-evolving landscape of life sciences.